Stocks Special Reports LICs Hybrids Technical Analysis Funds ETFs Tools SMSFs
Learn
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features Hybrids Technical Analysis SMSFs Learn Fund Times Ask the Analyst China Wrap
About

Company News Summary

ResMed Announces Record Financial Results for the Six Months Ended 21 December 2012

25 Jan 2013  |  09:15:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Record Financial Results for Q/E & 6 Months Dec 31, 2012

ResMed announced record revenue and income for the quarter ended 31 December 2012. Revenue for the quarter was $376.5m, a 13% increase (a 14% increase on a constant currency basis) over the quarter ended 31 December 2011. Net income was $77.9m, an increase of 24% compared to the quarter ended 31 December 2011. Diluted EPS for the quarter were $0.53, an increase of 26% compared to the previous corresponding quarter. For the six months ended 31 December 2012, revenue was $716.3m, an increase of 11% over the six months ended 31 December 2011 (a 13% increase on a constant currency basis). Net income for the six months was $149.2m, an increase of 32% compared to the pcp. Diluted EPS for the six months were $1.02 per diluted share, an increase of 36% compared to the pcp.

Please click here for full details

See more ASX300 News Announcements